| 标题 |
Letter Re: A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial Letter Re:在HR阳性/HER2阴性早期乳腺癌患者中辅助ribociclib联合内分泌治疗与单独内分泌治疗的III期试验:NATALEE试验的最终侵袭性无病生存结果
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |